Stock Events

Stock Events

Search...

Protalix BioTherapeutics (PLX) Q1 2026 Earnings

18MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.06

-0.01

0.03

0.08

Details

Expected EPS

0.04

Actual EPS

-0.06

Surprise EPS

-0.1

Surprise Percent

+250%

Description

Protalix BioTherapeutics (PLX) has reported earnings of -0.06 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.